RU2020119175A3 - - Google Patents

Download PDF

Info

Publication number
RU2020119175A3
RU2020119175A3 RU2020119175A RU2020119175A RU2020119175A3 RU 2020119175 A3 RU2020119175 A3 RU 2020119175A3 RU 2020119175 A RU2020119175 A RU 2020119175A RU 2020119175 A RU2020119175 A RU 2020119175A RU 2020119175 A3 RU2020119175 A3 RU 2020119175A3
Authority
RU
Russia
Application number
RU2020119175A
Other versions
RU2020119175A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2020119175A publication Critical patent/RU2020119175A/ru
Publication of RU2020119175A3 publication Critical patent/RU2020119175A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
RU2020119175A 2017-12-14 2018-12-13 Гликозидные производные трепростинила RU2020119175A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17207329.8A EP3498283A1 (en) 2017-12-14 2017-12-14 Glycosidic derivatives of treprostinil
EP17207329.8 2017-12-14
PCT/EP2018/084779 WO2019115702A1 (en) 2017-12-14 2018-12-13 Glycosidic derivatives of treprostinil

Publications (2)

Publication Number Publication Date
RU2020119175A RU2020119175A (ru) 2022-01-14
RU2020119175A3 true RU2020119175A3 (ru) 2022-01-14

Family

ID=60673569

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2020119175A RU2020119175A (ru) 2017-12-14 2018-12-13 Гликозидные производные трепростинила

Country Status (15)

Country Link
US (1) US11427609B2 (ru)
EP (2) EP3498283A1 (ru)
JP (1) JP7295877B2 (ru)
KR (1) KR20200099134A (ru)
CN (1) CN111447933A (ru)
AU (1) AU2018382556B2 (ru)
BR (1) BR112020010945A2 (ru)
CA (1) CA3085398A1 (ru)
CL (1) CL2020001559A1 (ru)
IL (1) IL275127B2 (ru)
MX (1) MX2020006173A (ru)
RU (1) RU2020119175A (ru)
SG (1) SG11202005360TA (ru)
WO (1) WO2019115702A1 (ru)
ZA (1) ZA202002725B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023529828A (ja) 2020-06-09 2023-07-12 ユナイテッド セラピューティクス コーポレイション トレプロスチニルのフマリルジケトピペリジンプロドラッグ

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814438D0 (en) 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
US6521212B1 (en) 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
JP2003523935A (ja) 1999-03-31 2003-08-12 ユナイテッド セラピューティクス コーポレイション 末梢血管疾患と肺高血圧症を治療するためのプロスタグランジン化合物、組成物および方法
US20030108512A1 (en) 2001-12-10 2003-06-12 Robert Shorr Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer
CN100558351C (zh) 2003-05-22 2009-11-11 联合治疗公司 化合物和释放前列环素类似物的方法
DK3851447T3 (da) 2006-10-12 2023-12-04 Bellus Health Inc Fremgangsmåder, forbindelser, sammensætninger og vehikler til administration af 3-amino-1-propansulfonsyre
ES2612510T3 (es) 2011-02-07 2017-05-17 Scipharm Sàrl Composición novedosa para el tratamiento de fibrosis quística
CN103857413A (zh) 2011-08-12 2014-06-11 阿森迪斯药物股份有限公司 载体连接的曲罗尼尔前药
HUE034485T2 (en) 2012-06-15 2018-02-28 Scipharm Sarl Process for the preparation of treprostinil and its derivatives
US20150315114A1 (en) 2012-12-07 2015-11-05 Cayman Chemical Company Incorporated Methods of Synthesizing a Prostacyclin Analog
JP6542128B2 (ja) 2013-01-11 2019-07-10 コルセア ファーマ インコーポレイテッド トレプロスチニルのプロドラッグ
US9505737B2 (en) * 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
WO2016120311A1 (en) 2015-01-27 2016-08-04 Scipharm Sàrl Composition for the treatment of hepatic veno-occlusive disease
US9394227B1 (en) * 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9643911B2 (en) * 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof

Also Published As

Publication number Publication date
IL275127B2 (en) 2023-11-01
CN111447933A (zh) 2020-07-24
IL275127A (en) 2020-07-30
MX2020006173A (es) 2020-10-12
CL2020001559A1 (es) 2021-03-12
EP3498283A1 (en) 2019-06-19
WO2019115702A1 (en) 2019-06-20
US11427609B2 (en) 2022-08-30
AU2018382556B2 (en) 2024-03-14
CA3085398A1 (en) 2019-06-20
SG11202005360TA (en) 2020-07-29
US20210087216A1 (en) 2021-03-25
EP3723769A1 (en) 2020-10-21
RU2020119175A (ru) 2022-01-14
IL275127B1 (en) 2023-07-01
JP7295877B2 (ja) 2023-06-21
ZA202002725B (en) 2021-08-25
AU2018382556A1 (en) 2020-05-28
JP2021506959A (ja) 2021-02-22
BR112020010945A2 (pt) 2020-11-17
KR20200099134A (ko) 2020-08-21

Similar Documents

Publication Publication Date Title
BR122021024395A2 (ru)
BR122021023687A2 (ru)
BR122022003522A2 (ru)
BR122022025811B8 (ru)
BR122021000189A2 (ru)
BR112019008823A2 (ru)
BR112020006084A8 (ru)
BR122021014832A2 (ru)
BR112020008820A2 (ru)
BR102017023327A2 (ru)
BE2017C035I2 (ru)
BR102017015495A2 (ru)
BR102017014430A2 (ru)
BR202017012548U2 (ru)
BR202017011220U2 (ru)
BR202017010814U2 (ru)
BR202017010373U2 (ru)
BR202017009870U2 (ru)
BR202017006953U2 (ru)
BR202017004898U2 (ru)
BR102017003115A2 (ru)
BR202017002937U2 (ru)
BR202017002826U2 (ru)
CN304043935S (ru)
CN304026747S (ru)